Literature DB >> 19399786

Systemic inflammatory response predicts postoperative outcome in patients with liver metastases from colorectal cancer.

Mitsuru Ishizuka1, Junji Kita, Mitsugi Shimoda, Kyu Rokkaku, Masato Kato, Tokihiko Sawada, Keiichi Kubota.   

Abstract

BACKGROUND: Few studies have investigated the Glasgow Prognostic Score (GPS) in patients with liver metastases from colorectal cancer (LM-CRC).
METHODS: The GPS was calculated as follows: patients with both an elevated level of CRP (>10 mg/L) and hypoalbuminemia (Alb <35 g/L) were allocated a score of 2, and patients showing one or neither of these blood chemistry abnormalities were allocated a score of 1 or 0, respectively.
RESULTS: Ninety-three patients were evaluated retrospectively. Kaplan-Meier analysis and log rank test revealed that a higher GPS predicted a higher postoperative death (P < 0.0001). Univariate analysis revealed that sex, number of hepatectomy, number of tumors, synchronous lung metastasis and CRP were associated with postoperative death. Multivariate analysis revealed that number of hepatectomy (odds ratio, 3.193; 95% CI, 1.093-9.330; P = 0.0338), number of tumors (odds ratio, 2.946; 95% CI, 1.094-7.931; P = 0.0325), synchronous lung metastasis (odds ratio, 3.424; 95% CI, 1.055-11.11; P = 0.0404) and CRP (odds ratio, 4.509; 95% CI, 1.313-15.49; P = 0.0167) were associated with postoperative death.
CONCLUSIONS: GPS is able to classify patients with LM-CRC into three independent groups. Among the selected factors, CRP is considered an important and high sensitive predictor of postoperative death in such patients. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19399786     DOI: 10.1002/jso.21294

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  18 in total

1.  Immune-related Genes to Dominate Neutrophil-lymphocyte Ratio (NLR) Associated With Survival of Cetuximab Treatment in Metastatic Colorectal Cancer.

Authors:  Yu Sunakawa; Dongyun Yang; Shu Cao; Wu Zhang; Miriana Moran; Stephanie H Astrow; Jack Hsiang; Craig Stephens; Akihito Tsuji; Takehiro Takahashi; Hiroaki Tanioka; Yuji Negoro; Akinori Takagane; Satoshi Tani; Tatsuro Yamaguchi; Tetsuya Eto; Masashi Fujii; Wataru Ichikawa; Heinz-Josef Lenz
Journal:  Clin Colorectal Cancer       Date:  2018-08-23       Impact factor: 4.481

2.  Usefulness of Inflammation-Based Prognostic Score in Patients Undergoing Lung Metastasectomy for Colorectal Carcinoma.

Authors:  Satoru Kobayashi; Yoko Karube; Morimichi Nishihira; Takashi Inoue; Osamu Araki; Tetsu Sado; Masayuki Chida
Journal:  World J Surg       Date:  2016-07       Impact factor: 3.352

3.  Systemic inflammatory response associated with distant metastasis of T1 or T2 colorectal cancer.

Authors:  Mitsuru Ishizuka; Hitoshi Nagata; Kazutoshi Takagi; Keiichi Kubota
Journal:  Dig Dis Sci       Date:  2010-03-03       Impact factor: 3.199

4.  Neutrophil-to-lymphocyte ratio has a close association with gangrenous appendicitis in patients undergoing appendectomy.

Authors:  Mitsuru Ishizuka; Takayuki Shimizu; Keiichi Kubota
Journal:  Int Surg       Date:  2012 Oct-Dec

5.  Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patients.

Authors:  Vincenzo Formica; Jessica Luccchetti; David Cunningham; Elizabeth C Smyth; Patrizia Ferroni; Antonella Nardecchia; Manfredi Tesauro; Vittore Cereda; Fiorella Guadagni; Mario Roselli
Journal:  Med Oncol       Date:  2014-08-23       Impact factor: 3.064

6.  Glasgow prognostic score is a practical predictive index for postoperative intra-abdominal septic complications after bowel resection in Crohn's disease patients.

Authors:  Yibin Zhu; Haili Xu; Wei Liu; Weilin Qi; Xiaoyan Yang; Lingna Ye; Qian Cao; Wei Zhou
Journal:  Int J Colorectal Dis       Date:  2018-04-23       Impact factor: 2.571

7.  Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases.

Authors:  Christopher P Neal; Vaux Cairns; Michael J Jones; Muhammad M Masood; Gael R Nana; Christopher D Mann; Giuseppe Garcea; Ashley R Dennison
Journal:  Med Oncol       Date:  2015-03-26       Impact factor: 3.064

8.  Prognostic significance of the preoperative serum C-reactive protein level in patients with stage IV colorectal cancer.

Authors:  Masatsune Shibutani; Kiyoshi Maeda; Hisashi Nagahara; Eiji Noda; Hiroshi Ohtani; Yukio Nishiguchi; Kosei Hirakawa
Journal:  Surg Today       Date:  2014-05-10       Impact factor: 2.549

9.  Role of systemic inflammation scores in pulmonary metastasectomy for colorectal cancer.

Authors:  Tommaso Claudio Mineo; Federico Tacconi
Journal:  Thorac Cancer       Date:  2014-08-25       Impact factor: 3.500

10.  Prognostic significance of C-reactive protein polymorphism and KRAS/BRAF in synchronous liver metastasis from colorectal cancer.

Authors:  Chi-Jung Huang; Hao-Wei Teng; Chih-Cheng Chien; Jen-Kou Lin; Shung-Haur Yang
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.